08048035996
Spnib 100 mg Good Quality Tablet to UK - London | Phoenix Exim | Trusted Exporter

1. General Information

Spnib 100 mg Tablet is an oral anticancer medicine containing Dasatinib 100 mg. It is a targeted therapy belonging to the tyrosine kinase inhibitor class. It is prescribed for specific blood and bone-marrow cancers and should be used only under the supervision of a qualified oncologist or physician.

  • Brand: Spnib 100 mg
  • Active ingredient: Dasatinib 100 mg
  • Dosage form: Tablet
  • Therapeutic class: Anticancer / Tyrosine Kinase Inhibitor
  • Prescription status: Prescription medicine
  • Manufacturer/marketer: Zydus Lifesciences Limited
  • Typical pack: 30 tablets
  • Storage: Store below 30°C, according to product information.

2. Product Information

Dasatinib works as a targeted cancer medicine by inhibiting specific tyrosine kinases involved in abnormal cancer-cell growth. Spnib 100 mg is available as an oral tablet and the exact dose and treatment duration are determined by the treating physician according to the patient's disease, response and other clinical factors.

3. Uses of Spnib 100 mg

Spnib 100 mg is primarily used in the management of:

  • Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
  • Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)
  • Certain CML cases where previous therapy has failed or was not tolerated.

The exact indication, treatment line and dosage should be determined by an oncologist.

4. Benefits of This Medicine

The principal benefit of Dasatinib is its targeted action against abnormal signaling proteins involved in leukemia-cell growth. By inhibiting BCR-ABL and other relevant kinases, it can suppress the growth and multiplication of abnormal blood cells and help control disease progression.

It may therefore help:

  • Control abnormal leukemia-cell growth
  • Reduce disease activity
  • Achieve and maintain a therapeutic response in appropriate patients
  • Provide a targeted treatment option for Ph+ leukemia

Important: It is not appropriate to describe Spnib as a general "cure" for cancer; treatment response varies between patients.

5. Side Effects

Like other anticancer medicines, Spnib 100 mg can cause adverse effects. Reported reactions include:

  • Pleural effusion
  • Headache
  • Nausea and vomiting
  • Diarrhea
  • Abdominal pain
  • Fatigue
  • Muscle or joint pain
  • Skin rash or itching
  • Edema/swelling
  • Anemia
  • Reduced platelet or neutrophil counts
  • Bleeding or gastrointestinal bleeding
  • Changes in blood pressure
  • Pulmonary hypertension
  • Heart-related complications in some patients.

Some reactions can be serious and require prompt medical attention.

6. Common Side Effects

Some commonly reported effects include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal discomfort
  • Headache
  • Fatigue
  • Rash
  • Muscle or joint pain
  • Swelling
  • Changes in blood-cell counts.

If symptoms are persistent, severe or unusual, the patient should contact the treating physician.

7. How to Use

Spnib 100 mg should be taken exactly as prescribed by the doctor.

  • Swallow the tablet whole with water.
  • Do not crush, chew or break the tablet unless specifically instructed by a healthcare professional.
  • It may generally be taken with or without food.
  • Try to take it at approximately the same time each day.
  • Do not change the dose or discontinue treatment without medical advice.

The prescribed dose can vary according to the type of leukemia, age, treatment response, other medicines and the patient's overall health.

8. How Spnib 100 mg Works

Spnib contains Dasatinib, which blocks several tyrosine kinases, including BCR-ABL and Src-family kinases. BCR-ABL is associated with abnormal signaling in Philadelphia chromosome-positive leukemia.

By inhibiting these signaling pathways, Dasatinib can interfere with the growth and multiplication of abnormal leukemia cells.

9. Safety Advice

Pregnancy: Dasatinib can cause serious harm to an unborn baby. Patients who are pregnant or planning pregnancy should discuss treatment with their physician.

Breastfeeding: Breastfeeding is generally not recommended during treatment; discuss this with the treating doctor.

Liver problems: Patients with liver disease should inform their doctor because additional caution or dose adjustment may be required.

Blood counts: Dasatinib can reduce blood-cell counts, so regular blood tests may be required during treatment.

Bleeding: The medicine may increase the risk of bleeding. Unusual bleeding, blood in stools or urine, or severe unexplained bruising should be reported promptly.

Heart and lungs: Seek medical attention for breathing difficulty, chest pain, persistent cough, palpitations or significant swelling because serious pulmonary or cardiovascular complications can occur.

Drug interactions: Tell the doctor about all prescription medicines, OTC medicines and supplements being used. Some medicines can affect Dasatinib levels or increase adverse-effect risks.

10. Frequently Asked Questions

Q1. What is Spnib 100 mg used for?
It is used for certain Philadelphia chromosome-positive blood cancers, particularly CML and Ph+ ALL.

Q2. What is the active ingredient in Spnib 100 mg?
It contains Dasatinib 100 mg.

Q3. Is Spnib 100 mg a chemotherapy medicine?
It is an anticancer medicine, specifically a targeted tyrosine kinase inhibitor, rather than conventional cytotoxic chemotherapy.

Q4. Can Spnib 100 mg be taken with food?
It can generally be taken with or without food, but patients should follow their physician's instructions.

Q5. Can I stop Spnib 100 mg when I feel better?
No. Treatment should not be stopped or changed without the oncologist's advice.

Q6. Can Spnib cause breathing problems?
Yes. Pleural effusion and other pulmonary complications are recognized risks. Difficulty breathing, chest pain or persistent cough should be reported promptly.

Q7. Does Spnib require a prescription?
Yes. It is a prescription anticancer medicine and should be used under medical supervision.

11. Substitute for Spnib 100 mg

Because Spnib 100 mg contains Dasatinib 100 mg, potential same-strength alternatives may include other Dasatinib 100 mg brands such as:

  • Invista 100 Tablet
  • Dasatib 100 mg Tablet
  • Daslemia 100 Tablet
  • Beedan 100 mg Tablet

Availability varies by country and market.

Do not switch brands or treatment without approval from the prescribing oncologist. A substitute should match the prescribed active ingredient, strength and dosage form and be appropriate for the individual patient's treatment.

12. SEO & B2B Keywords

  1. Spnib 100 mg Tablet exporter from India
  2. Spnib 100 mg Dasatinib Tablet exporter
  3. Spnib 100 mg supplier from Nagpur India
  4. Dasatinib 100 mg Tablet pharmaceutical exporter
  5. Spnib 100 mg wholesale supplier India
  6. Spnib 100 mg bulk medicine supplier
  7. Spnib 100 mg Tablet international supplier
  8. Dasatinib 100 mg oncology medicine exporter India
  9. Spnib 100 mg CML medicine supplier
  10. Spnib 100 mg leukemia medicine exporter
  11. Dasatinib 100 mg CML treatment supplier
  12. Spnib 100 mg Ph+ leukemia medicine
  13. Spnib 100 mg pharmaceutical wholesaler India
  14. Spnib 100 mg medicine exporter Nagpur
  15. Spnib 100 mg supplier USA
  16. Spnib 100 mg supplier UK
  17. Spnib 100 mg supplier Australia
  18. Spnib 100 mg supplier Canada
  19. Spnib 100 mg supplier Singapore
  20. Spnib 100 mg supplier South Korea
  21. Spnib 100 mg supplier UAE
  22. Dasatinib 100 mg exporter to USA
  23. Dasatinib 100 mg exporter to UK
  24. Dasatinib 100 mg exporter to Australia
  25. Dasatinib 100 mg exporter to Canada
  26. Dasatinib 100 mg exporter to Singapore
  27. Dasatinib 100 mg exporter to South Korea
  28. Dasatinib 100 mg exporter to UAE
  29. Spnib 100 mg oncology pharmaceutical supplier
  30. Spnib 100 mg trusted medicine exporter from India
Aug 13th, 2026 3:16 PM

Keywords